학술논문

Ibrutinib as first line therapy in chronic lymphocytic leukemia patients over 80 years old: A retrospective real‐life multicenter Italian cohort.
Document Type
Article
Source
Hematological Oncology; Jan2024, Vol. 42 Issue 1, p1-9, 9p
Subject
CHRONIC lymphocytic leukemia
RICHTER syndrome
HEART failure
ACUTE coronary syndrome
ATRIAL fibrillation
PROGRESSION-free survival
Language
ISSN
02780232
Abstract
Copyright of Hematological Oncology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)